Panel discussion on Intellectual Property and the Constitution: accessibility, vaccine waivers and content creationTaera Singh·April 16, 2022
Patent and Patient Rights in COVID-19: Is the Right to Exclusivity a Hamlet Question?Justice Prabha Sridevan·October 8, 2020
Plea filed in SC seeking directions to Centre to issue compulsory licenses for patents on Remdesivir, Favipiravir, TocilizumabThe Leaflet·April 29, 2021
Policing the internet: Kerala’s increasing crackdown on free speech onlineMuhammed M.P.·December 1, 2023
Statement by Indian Civil Society: Need for open innovation and knowledge sharing for COVID-19 healthcare through Indian IP lawsThe Leaflet·June 24, 2020
The need for access to anti-TB drugs in India: An interview with Anand GroverSarah Thanawala·April 1, 2023
World TB Day coincides with the Indian Patent Office rejecting J&J’s application to extend its patent on anti-tuberculosis drug BedaquilineSarah Thanawala·March 24, 2023